M Griffin Resume

1. 1
MAURA J. GRIFFIN, B.Sc.
Lean Six Sigma
29 Albany Road | Walpole, MA 02081
(508) 353-4303 | Maura-cape@hotmail.com
Market Access Leader
Respected National IDN/Market Access /Sales Leader with a strong background in Value Based Healthcare
Delivery and Healthcare Quality.
Builds out broad and deep relationships with Senior Leadership at the Health System Level, Payers, Medical
Societies, ACO’s and GPO’s to define the Health/Clinical and Economic Value of the company’s portfolio.
Identifies gaps, removes barriers and creates innovative solutions to secure formulary positioning within
IDN.
Collaborates with Company Leadership and Internal Teams to align with Company Strategic Initiatives and
Goals.
Leads Cross Functional Teams providing overall strategic and tactical leadership of collaborative
pull-through initiatives around assigned regional and national accounts creating stronger access.
Known as a passionate patient advocate, reinforced by a commitment to ethical business practice, strong
sense of urgency, attention to detail and strong clinical & business acumen.
EXPERTISE
Commercial Launches • Market Access Strategy & Execution • Building Collaborative Relationships • Value
Based Healthcare Expertise • Strong Marketplace Knowledge • Strategic Planning and Market Development
• Presenting Population Health Data, Budget Impact Models and Analytics • KOL Development • C-Suite
Partnerships • Process Improvement • Consultative Sales • Account Management • Building Innovative and
Profitable Contracts
CORE COMPETENCIES
Leadership • Cross Functional Collaboration • Interpersonal Awareness • Fostering Teamwork •
Strategic Thinking • Analytical Thinking • Attention to Communication • Persuasive Communication •
Presentation Skills
CALL POINT EXPERIENCE
Health Systems Executive Leadership • C-Level Executives (CEO, CMO, CFO, & CNO) • KOLs •
VPs/Directors/Dept Heads (Population Health, Quality, Nursing, Pharmacy, Finance, Supply Chain)
Integrated Delivery Networks (IDNs) • Group Purchasing Organizations (GPOs)
Physician Hospital Organizations • Hospitals (Acute, Subacute, & Extended Care) • Medical Society and
Forums Leadership
EDUCATION
HARVARD BUSINESS SCHOOL | Executive Education Program
Value Measurement for Healthcare, 2018
HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH | EXECUTIVE PROFRESSIONAL EDUCATION
Measurement, Design, and Analysis Methods for Health Outcomes Research, 2018
UNIVERSITY OF MASSACHUSETTS, BOSTON
BS | Bachelor of Science, Biology

2. 2
NOTABLE HIGHLIGHTS
Portola Pharmaceuticals 2017- 2018
• Built Partners Healthcare into a National Center of Excellence.
• Developed, implemented and executed high-level strategies that achieved a positive Systemwide
Formulary Position system of Bevyxxa and Andexxa in a Prestigious Health Care System, Partners
Healthcare.
• Developed and grew high level partnerships with Executive Steering Committee Members/Clinical
Trialists, National Thrombosis, Hematology Experts, Hospital Medicine and Pharmacy Thought
Leaders to influence the adoption of a new paradigm, Extended Duration Prophylaxis of the Acute
Medically Ill Patient.
• Engaged and collaborated with Clinical Leadership (Pharmacy,Anticoagulation Experts,Hematology,
Neurosurgery, Neurocritcal Care) and Corporate Partners to provide support for the development of
treatment paradigms and assisted in the development of an implementation plan housewide for
Andexxa.
• Collaborated with the Executive Chief of Pharmacy at Brigham & Women’s Hospital to build the
platform for EHR implementation, visibility of both therapies within EPIC for ease of prescribing
with providers.
• Collaborated with Senior Nursing Leadership and Pharmacy to develop an educational platform for
Nursing and Mid-levels.
• Initiated, project managed and led the development of two House Wide Collaborative Quality
Improvement Projects at Brigham & Women’s Hospital.
• Formed and aligned a multidisciplinary Clinical Leadership Team in collaboration with the Executive
Chief of Pharmacy to support both Quality Improvement Projects.
• Grew and maintained a Corporate Partnership with Corporate Leadership of the NATF (North
American Thrombosis Forum).
• Initiated, led and grew the development of a Corporate Partnership with Executive Leadership of
PERT (Pulmonary Embolism Response Team) and Corporate Leadership at Portola.VGB
GVHDB
Mallinckrodt Pharmaceuticals 2012-2017
• Achieved System Wide approval of Ofirmev and addition of Colorectal ERAS onto the System Wide
Order sets at Partners Healthcare.
• In 2017 established a formal collaboration between Senior Leadership at the Massachusetts Hospital
Association and Mallinckrodt to form a Pain Stewardship Program and Initiative.
• Established multiple collaborative HEOR projects with Senior Clinical Research Leadership within
Harvard/Partners Healthcare.
• 2015-2016- Q2 #16 Nationally.
• 2015 Presidents Club Advisory Board.
• 2014 Presidents Club; National Ranking #10; Top Volume Award (National).
• 2013 Ranked #17 Nationally; Recipient of the Core Values Award, New England District.
Pacira Pharmaceuticals 2011-2012
• Launched Exparel, (bupivacaine liposome Injectable suspension) a new technology and Non-Opioid
indicated to produce postsurgical local analgesia.
• Successfully aligned champions to support addition to formulary in Major Health Systems in Boston.
Canyon Pharmaceutical Group 2010-2011

3. 3
• Identified Massachusetts General Hospital (MGH) as the Nation’s largest DTI Volume Account worth
$1 Million in gross sales, 12% of the worldwide gross sales of Argatroban.
• Achieved Formulary approval for Desirudin at MGH; partnered with MGH Executive, Clinical and
Pharmacy Business Leadership to coordinate a successful Formulary approval; and achieved
Formulary Acceptance with minimal restrictions and inclusion on all order sets/protocols.
Daiichi Sankyo 2008-2010
• Successfully launched a novel third generation Thienopyridine, Effient, against an $8 Billion-dollar
Competitor, Plavix. Ranked #9 Nationally.
• Gained P&T approval and formulary acceptance on the day of launch onto Brigham & Women’s
Hospital Formulary and P&T approval and stocking in all Harvard Academic Hospitals within 2
months of launch; Established Effient as first line therapy on Institutional Guidelines & Protocols.
PDL Biopharma 2006-2008
• Initiated the business strategy that resulted in $1 Million of new business and the stocking of Cardene
in the Anesthesia Department and Interventional Radiology at Mass General Hospital by utilizing a
national thought leader to influence MGH colleagues to change practice.
• Increased Sales revenues 25% in key accounts over projected sales quota in a newly realigned
territory.
• Increased market share from 0 to 27%; gained formulary acceptance & first line status at SCHS.
Scios 2001-2006
• Ranked #8 nationally, 2004 Sales Excellence Award
• 2004, 2005 & 2006 Ranked in top 10 nationally.
• 2004, 2005 & 2006 Ranked #1 in Sales and Achievements, Boston Business Unit.
• Outstanding Regional Sales Contribution Award, Northeast Region.
Genentech 1997-2001
• 2001 Achieved 100% Genentech Market Share.
• 2000 Ranked #3 Regionally & Nationally in Market share.
• 1999 & 2000 Achieved Cardiovascular Sales Achievement Award.
• 1999 Achieved National Market Share Excellence Award.
• 1998 Cardiovascular Sales Excellence Award.
• 1998 & 2000 Achieved highest dollar volume increase regionally, 1998 & 2000.
• Grew market share to 90% + in a declining lytic market where the national market share was 60% and
the competitor was 2/3 of the price.
• Directed the efforts of the NRMI 4 (National Registry of Myocardial Infarction) with Physician
Investigators and Hospital Leadership within participating Hospitals in the Northeast.
KEY PROFESSIONAL SKILLS
MARKET ACCESS LEADERSHIP
• Implements a market access sales and marketing strategy that is aligned to maintain, protect, expand
and enhance Hospital and Managed Care Organization (MCO) formulary access and/or
reimbursement for products within assigned accounts.
• Provides overall strategic and tactical leadership of collaborative pull-through initiatives with sales
leadership around assigned regional and national accounts.
• Conducts critical analysis of all data sources to create a Strengths, Weaknesses, Opportunities and
Threats (SWOT) Analysis to share with cross-functional leadership.
• Implements and communicates the Market Access strategy for the organization; establishes short-
term and long-term goals to address access related barriers with customers.
BUSINESS DEVELOPMENT | TERRITORIAL PLANNING
• Utilizes relationships, experience and current knowledge of the Market/Health Systems to identify
and map out Key Stakeholders who have the power and influence to make an impact (Clinical Practice
change) on the current state of business.

4. 4
• Develops and proposes novel strategies that are based on current Market relevant factors (e.g., health
system strategy, product, competition and customer/pricing needs)
• Collaborates, communicates and coordinates with Internal Teams to gain their insight on interactions
to maximize business opportunities.
• Operates with the highest ethical standard during every customer and patient interaction and in
alignment with company philosophies and leadership principles.
RELEVANT EXPERIENCE
PORTOLA PHARMACEUTICALS, Parsippany NJ 2017 – 2018
Thrombosis Area Manager
IDN Commercial Team Leader, Partners Healthcare & Harvard Teaching Hospitals North
East
IDNs: Partners Healthcare, Beth Israel Deaconess Healthcare, Dartmouth Hitchcock Health System,
Yale New Haven Health System, Lahey Health, Lifespan, Maine Healthcare, Cape Cod Healthcare
GPOs: Vizient- Northeast Purchasing Coalition, Yankee Alliance
• Commercial Launch Team Leader Partners Healthcare -Led a Cross Functional Team that was
specifically focused on achieving Formulary Acceptance on the System Level.
• Developed, coordinated and executed complex strategies with Senior Executive Commercial
Leadership, Medical Executive and Senior Leadership, Medical Affairs and National Accounts
that led to a positive Systemwide Formulary Position of Bevyxxa and Andexxa meeting and
exceeding Company Strategic Initiatives.
• Qualified, engaged, educated and aligned champions throughout the Partners Enterprise on the
value proposition, HEOR and Budget Impact of Portola’s therapies to gain buy in with Hospital
Leadership for P&T.
• Collaborated with the Executive Chief of Pharmacy at Brigham & Women’s Hospital to build the
platform for EHR implementation, visibility of both therapies within EPIC for ease of prescribing
with providers.
• Interfaced with Corporate Operations regarding product packaging to ensure smooth transition
through the supply chain and product availability throughout the enterprise in both inpatient
and outpatient usage.
• Built educational platform for Nursing with Senior Nursing Leadership and Pharmacy.
• Presented Population Health Data, Budget Impact Modeling and Hospital Specific Data Analytics
to Population Health Decision Makers from Health System Pharmacy Leadership, Quality and
Safety Leadership, Hospital Leadership and GPO Leadership to influence formulary inclusion of
Bevyxxa and Andexxa to aid in identifying appropriate use criteria, Clinical Decision Making and
integration into EHR and Treatment Plans.
MALLINCKRODT PHARMACEUTICALS, St. Louis MI 2012 – 2017
National Director, Corporate Account Solutions Quality Leader- Northeast (2015 – 2017)
IDNs: Partners Healthcare, Hartford Healthcare, Trinity St. Francis Healthcare, Baystate Health, Yale
New Haven Health System, Dartmouth Hitchcock, Albany Medical Center.
GPOs: NPC-North East Purchasing Coalition. Trinity, Tenet and Ascension Healthcare in the North East.
Developed National and Regional IDN relationships and access of new, launch or in-line product
opportunities.
• Secured formulary positioning within IDN and managed GPO and Direct Contracts and value
proposition.
• Delivered Clinical and Economic Value of Multimodal Pain Management to Chiefs of Pharmacy,

5. 5
System VP’s of Pharmacy, Senior Healthcare Leadership within IDN’s, Healthcare Systems and
GPO’s.
• Developed and directed Field Account Teams specific to IDN Targets. Collaborated with Internal
Stakeholders to achieve Company Strategic Imperatives.
Hospital Sales Specialist (2012 – 2015)
• Partners Healthcare, Tufts, Boston Medical Center, Steward Healthcare, New England Baptist,
South Shore, BI Plymouth, Cape Cod Healthcare, and South Coast Hospital System.
• Marketed Ofirmev (Acetaminophen for Injection) to Anesthesiologists, Surgeons, Pain
Management Teams, Trauma, Critical Care, Midlevel Practitioners. Presented Value Proposition
to Quality & Safety, CMO’s CNO’s & Clinical Leadership to achieve company objectives.
PACIRA PHARMACEUTICALS, Parsippany, NJ 2011 – 2012
Boston Academic Centers, Partners Healthcare, Tufts, Boston Medical Center, Steward Hospital System,
Lahey Clinic, U Mass Health System and Lifespan.
Launched Exparel, a liposomal injection of Bupivacaine.
• Successfully aligned champions to support addition to formulary at Mass General, Brigham &
Women’s, Beth Israel Deaconess, Tufts, Boston Medical Center, Lahey Clinic, U Mass, New
England Baptist Hospital, Faulkner, Hallmark Health, Mt Auburn, Winchester, Cape Cod
Hospital & Wing Memorial.
• Obtained position on Hospital P&T agendas at Brigham & Women’s Hospital, Faulkner, NE
Baptist, Tufts, BMC, Lahey, Clinic, Hallmark Health, Winchester & Wing Memorial.
CANYON PHARMACEUTICAL GROUP, Parsippany, NJ 2010 – 2011
Regional Account Manager, Anticoagulation Specialist
Partners Healthcare, Harvard & Brown Academic Centers, Yale New Haven, Maine Medical Center, and
Dartmouth & Fletcher Allen Healthcare.
• Launched Iprivask, a novel SC Direct Thrombin Inhibitor. Identified high volume potential
accounts and collaborated with GM, VP of Global Medical Affairs and the VP of Sales to secure
pull through of Desiruidn into Partners Healthcare flagship Hospitals.
DAIICHI SANKYO, Parsippany, NJ 2008– 2010
Hospital Sales Specialist, Boston | Harvard, BU, Tufts & Seward
Hospital Clinical Advisory Team | National Team Member
Clinical Trainer | Boston
• Hired in as the Company Wide Hospital Sales Leader to launch Effient in the Boston Hospital
Market. US Hospital Division Lead for Daiichi’s Cross Functional Team in two organizations
(Daiichi and Lilly).
• Coordinated all sales efforts amongst the hospital and retail sales team. Established account
goals and coordinated strategic pull through and sales tactics to meet corporate goals in
nationally identified high- profile accounts.
• Collaborated with an In House Cross Functional Team that included Medical Affairs, Senior
Hospital & Retail Sales Management, Brand Strategy and National Accounts to achieve a
successful launch and position Daiichi as the Market Leader.

6. 6
PDL BIOPHARMA, Redwood City, CA 2006– 2008
Senior Hospital Sales Representative
Boston Academic Medical Centers, Providence, Worcester, Hartford Member, Marketing Advisory
Board, Northeast Region/Leader, Northeast Region, and Promotional Program Delivery
• Marketed Cardene, a third generation Dihydropyridine CCB to Neurosurgery, Interventional
Neuro Radiology, Anesthesia, Critical Care, Cardiovascular/Thoracic Surgery, Labor & Delivery
and Emergency Departments.
SCIOS, Freemont, CA 2001– 2006
Senior Cardiovascular Specialist, Boston South Territory
Member, National ADHERE Registry Team Leader
Scios Regional Advisory Board, Medical Education Board, 2005
• Launched a new class of recombinant drug, B-Naturietic Peptide, in Acute Decompensated Heart
Failure with a new start up company.
GENETECH, San Francisco, CA 1997– 2001
Senior Clinical Specialist, Cardiovascular Medicine – Boston South Territory
Regional Team Leader, Integrated Hospital Systems (2000)
Northeast Regional Trainer (1999 – 2001)
Product Team Leader, New England Division (1998 – 1999)
Advocate Team leader (2000-2001)
• Promoted Recombinant Alteplase for Acute MI, Acute Ischemic Stroke, Pulmonary Embolism;
Co-Marketed Integrillin, a glycoprotein llb llla inhibitor with Cor Therapeutics.
CERTIFICATIONS & PROFESSIONAL DEVELOPMENT
Lean Six-Sigma l Yellow Belt • STEEEP Academic Leadership Series’ • Value Based Negotiation Training
PROFESSIONAL AFFILIATIONS
ACHE | American College of Healthcare Executive, State Member • MAHQ | Massachusetts
Association of Healthcare Quality, Member • NPSF | National Patient Safety Foundation, Member
NATF | North American Thrombosis Forum